Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

SZSE:002675.SZ

17.35 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 3,275.6483,582.9553,912.053,418.9782,992.7612,332.8231,595.6011,158.451794.916751.022774.73587.754857.573663.628376.458323.389
Cost of Revenue 1,805.9582,044.3752,309.8761,718.7781,216.521995.83725.429612.517493.275502.576593.456413.497656.158565.66312.145277.505
Gross Profit 1,469.691,538.581,602.1741,700.1991,776.241,336.993870.172545.934301.641248.446181.274174.257201.41597.96964.31445.884
Gross Profit Ratio 0.4490.4290.410.4970.5940.5730.5450.4710.3790.3310.2340.2960.2350.1480.1710.142
Reseach & Development Expenses 197.223163.52137.558109.38788.71364.78539.8227.74338.14436.30815.3595.6750000.314
General & Administrative Expenses 68.1861.20875.47355.62348.9742.13933.15337.19619.23915.09113.8628.69627.69919.38615.4663.649
Selling & Marketing Expenses 507.51566.12592.284743.417832.851574.401333.548194.92180.32936.03317.79516.16811.0356.8036.2894.305
SG&A 575.69627.328667.757799.041881.821616.54366.702232.11799.56851.12331.65824.86338.73526.18921.7567.954
Other Expenses -23.97168.809150.846130.564137.639114.79986.01514.4386.3555.01628.3852.436.0140.7831.8980.837
Operating Expenses 963.295959.658956.161,038.9911,108.173796.124492.536317.415184.756129.07780.77755.58542.73226.77121.86716.842
Operating Income 341.662448.252630.319609.145603.942467.566314.169228.761128.174126.43396.619122.698144.81159.29936.46816.813
Operating Income Ratio 0.1040.1250.1610.1780.2020.20.1970.1970.1610.1680.1250.2090.1690.0890.0970.052
Total Other Income Expenses Net -36.446-2.675-274.222.23-208.1842.1821.2213.72717.55612.25724.4936.104-7.859-11.116-4.081-11.392
Income Before Tax 337.282445.576356.099611.375395.758469.748315.389242.246134.441131.626124.99124.776150.82560.08238.36617.65
Income Before Tax Ratio 0.1030.1240.0910.1790.1320.2010.1980.2090.1690.1750.1610.2120.1760.0910.1020.055
Income Tax Expense 83.06592.7695.24993.902102.11780.95550.65941.93122.90123.7621.20919.8422.8869.4556.0062.54
Net Income 209.736307.291260.85417.766293.64388.793264.73130.95389.745103.958100.85105.058127.93550.63931.98815.065
Net Income Ratio 0.0640.0860.0670.1220.0980.1670.1660.1130.1130.1380.130.1790.1490.0760.0850.047
EPS 0.250.380.330.520.370.510.380.20.140.20.190.230.330.130.0980.069
EPS Diluted 0.250.380.330.520.370.510.380.20.140.20.190.230.330.130.0980.069
EBITDA 634.047714.216745.25771.068699.993621.137413.808309.833178.003161.833143.544129.172167.74775.71748.90333.451
EBITDA Ratio 0.1940.1990.1910.2260.2340.2660.2590.2670.2240.2150.1850.220.1960.1140.130.103